Navigation Links
Cancer Doctors Okays Controversial Prostate Therapy

A controversial treatment for prostate cancer in which radioactive seeds are implanted in the prostate to destroy the tumor received support Friday from doctors writing therapy guidelines for the prestigious 17-hospital National Comprehensive Cancer Network (NCCN) meeting in Ft. Lauderdale, Fla. This type of therapy is known as brachytherapy, the procedure has been performed for years by researchers, but previous treatment guidelines for prostate cancer left the procedure out. "The weight of institutional experience at NCCN members allows us to expand the guidelines to include brachytherapy," said Dr. Howard Sandler, head of radiation therapy oncology at the University of Michigan Comprehensive Cancer Center one of the NCCN hospitals. Three years ago, when the NCCN produced its prostate cancer guidelines there was no mention of brachytherapy. "There was a lot of noise at the time about not putting brachytherapy in the guidelines," said Dr. Laurence Baker, associate chief of hematology/oncology at the University of Michigan and chairman of the committee writing the guidelines. The general consensus at the time, though, was that data on brachytherapy for prostate cancer still needed to mature before doctors were willing to consider it in the guidelines.
'"/>




Page: 1

Related medicine news :

1. Fibroids unlikely to Turn Cancerous
2. Virus Level could Predict Cervical Cancer Risk
3. Potential New Cancer Gene Identified
4. Consensus on "Combination Therapy" for Breast Cancer
5. Cancers of Colon & Rectum linked to Cigarette Smoking
6. Life Saving Cancer Drugs – From Chicken! Possible Says Dolly’ Creatos
7. The Cancer Rumour mill working over time
8. Cancer drugs in development nearly doubled since 1995
9. Radioactive Seeds used in Prostate Cancer treatment can migrate with the body
10. Cancer patients turning to Internet for information
11. ZD1839 Proves Effective - A Breakthrough in fighting Lung Cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/27/2017)... ... February 27, 2017 , ... New Jersey ranks among the ... types and genders. And the need for advanced services is growing. , Project ... cancer care program, in collaboration with their non-profit partners in their fight against cancer ...
(Date:2/26/2017)... Dublin, Ireland (PRWEB) , ... February 26, 2017 ... ... accreditation, as in 2011 the lab became the world’s first to be ISO/IEC ... d 1 (cat allergen) analysis. , ISO/IEC 17025:2005 is the globally recognised standard ...
(Date:2/26/2017)... ... ... IndustryArchive.Org . is announcing a new way for B2B Sellers to ... pay for B.A.N.T. quality sales leads based on the Sellers decision to purchase a ... that B2B buyers are controlling the sales process via the Internet and that ad ...
(Date:2/26/2017)... (PRWEB) , ... February 26, 2017 , ... ... patients after receiving cognitive rehabilitation, according to a study released today at the ... that cognitive rehabilitation programs are proven to be effective in improving cognitive function ...
(Date:2/24/2017)... ... February 24, 2017 , ... HealthPostures, expert standing ... benefits and advantages built into the home office sit stand solution are bold ... Ability to gain the benefits embedded in the TaskMate Go are available 24/7 ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... DUBLIN , Feb 23, 2017 Research and ... and Strategies - 2016" report to their offering. ... The latest research Menopause Drugs Price Analysis ... global Menopause market. The research answers the following questions: ... their clinical attributes? How are they positioned in the Global Menopause market? ...
(Date:2/23/2017)... Feb 23, 2017 Research and Markets has ... and Strategies - 2016" report to their offering. ... The latest research Oesophageal ... data and benchmarks in the global Oesophageal Cancer market. ... What are the key drugs marketed for Oesophageal Cancer and their ...
(Date:2/23/2017)... Calif. , Feb. 23, 2017 ... company focused on the development and commercialization of ... pain, announced that it will release fourth quarter ... Thursday, March 2nd, 2017. AcelRx management will host ... Time (1:30 p.m. Pacific Time) on March 2 ...
Breaking Medicine Technology: